sorafenib has been researched along with sepharose in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (sepharose) | Trials (sepharose) | Recent Studies (post-2010) (sepharose) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 7,485 | 10 | 1,669 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaudhari, P; Darshan, K; Dhawan, V; Joshi, G; Lokras, A; Marwah, M; Mohanty, B; Nagarsenker, M; Saraf, M; Venkatraman, M; Warawdekar, U | 1 |
1 other study(ies) available for sorafenib and sepharose
| Article | Year |
|---|---|
Polysaccharide and monosaccharide guided liver delivery of Sorafenib Tosylate - A nano-strategic approach and comparative assessment of hepatospecificity.
Topics: Drug Delivery Systems; Galactose; Ligands; Liposomes; Liver; Monosaccharides; Particle Size; Polysaccharides; Sepharose; Sorafenib; Tissue Distribution | 2022 |